Novo Nordisk shares fell 30% in the fourth quarter on disappointing clinical trial data, concerns about its experimental ...

It’s not at all clear what a tariff would mean for Novo, which manufactures its medicines in facilities all over the world, ...

When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion in sales in 2023, it shows no ...

Looking to expand its legacy in metabolic conditions, Novo Nordisk has inked a multiyear research pact with Variant Bio to better understand the genetics underlying disease across diverse populatio | ...

A new trend gaining popularity among people trying to lose weight is microdosing the diabetes medication Ozempic.

A mixture of macro fears for inflation and concerns about what the next Trump presidency may hold are dominating markets as we move to the middle of the week. The sell off in stocks in the US was ...

The energy giant said it expects the charge in the fourth quarter due to payments for emission certificates, and also anticipates results in its integrated gas division to be significantly lower than ...

European stock futures broadly edged lower with U.S. inflation worries back on the forefront. U.S. stocks fell sharply and bond yields spiked Tuesday after the latest services industry and job ...

The millennial-focused digital health company Hims & Hers (HIMS) has donated $1 million to President-elect Donald Trump’s ...

Since the start of 2020, Eli Lilly’s (NYSE: LLY) stock price chart has been straight up and to the right, up 478.78% and ...

Evaluate, the leading provider of market insights for the pharmaceutical industry, today released its 2025 Preview report featuring updated forecasts for the biopharma market for 2025.

Here are some of the drugs that are predicted to become blockbusters in the next few years, according to Clarivate's latest ...